Stenocare AS (OCSE:STENO) EV-to-EBIT : -0.45 (As of Apr. 28, 2025)

View and export this data going back to 2020. Start your Free Trial

What is Stenocare AS EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Stenocare AS's Enterprise Value is kr14.71 Mil. Stenocare AS's EBIT for the trailing twelve months (TTM) ended in Dec. 2024 was kr-32.98 Mil. Therefore, Stenocare AS's EV-to-EBIT for today is -0.45.

The historical rank and industry rank for Stenocare AS's EV-to-EBIT or its related term are showing as below:

OCSE:STENO' s EV-to-EBIT Range Over the Past 10 Years
Min: -160.67 Med: -6.34 Max: 2369.83
Current: -0.45

During the past 7 years, the highest EV-to-EBIT of Stenocare AS was 2369.83. The lowest was -160.67. And the median was -6.34.

OCSE:STENO's EV-to-EBIT is ranked worse than
100% of 681 companies
in the Drug Manufacturers industry
Industry Median: 16.39 vs OCSE:STENO: -0.45

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Stenocare AS's Enterprise Value for the quarter that ended in Dec. 2024 was kr28.55 Mil. Stenocare AS's EBIT for the trailing twelve months (TTM) ended in Dec. 2024 was kr-32.98 Mil. Stenocare AS's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2024 was -115.53%.

Stenocare AS EV-to-EBIT Historical Data

The historical data trend for Stenocare AS's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stenocare AS EV-to-EBIT Chart

Stenocare AS Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

EV-to-EBIT

Get a 7-Day Free Trial

-16.86

-7.65

-6.72

-2.90

-0.86

Stenocare AS Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
EV-to-EBIT	Get a 7-Day Free Trial															-2.90	-8.76	-5.75	-3.02	-0.86

Competitive Comparison of Stenocare AS's EV-to-EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, Stenocare AS's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Stenocare AS's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Stenocare AS's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Stenocare AS's EV-to-EBIT falls into.

Save Embed

;

Save Embed

;

Stenocare AS EV-to-EBIT Calculation

Stenocare AS's EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	14.712	/	-32.98
	=	-0.45

Stenocare AS's current Enterprise Value is kr14.71 Mil.
Stenocare AS's EBIT for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-32.98 Mil.

Stenocare AS (OCSE:STENO) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Stenocare AS's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2024 )	=	EBIT	/	Enterprise Value (Q: Dec. 2024 )
	=	-32.98	/	28.547253146
	=	-115.53 %

Stenocare AS's Enterprise Value for the quarter that ended in Dec. 2024 was kr28.55 Mil.
Stenocare AS's EBIT for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-32.98 Mil.

Stenocare AS EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Stenocare AS's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Stenocare AS Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Stenocare AS (OCSE:STENO) » Definitions » EV-to-EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

Nyholmsvej 4, Randers NØ, DNK, 8930

Website

https://www.stenocare.com

Stenocare AS is a Danish company engaged in the cultivation and production of medical cannabis products through pharmacies and hospitals. The Company's business operations include the distribution and sales of imported products to several markets which also includes local cultivation and production of its medical cannabis products. Stenocare is well positioned to become a market leader in Denmark and a vendor in Europe. The Company is a supplier of medical cannabis oil for patients in Denmerk, Sweden, UK, Australia and Norway. It has an indoor production facility for the cultivation and production of medical cannabis at Randers, Denmark.

Stenocare AS Headlines

No Headlines